Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells (Q57003105)

Fernando Rizzello

5

0 references

Massimo Campieri

Massimo Campieri

8

0 references

Paolo Gionchetti

Paolo Gionchetti

4

0 references

Elisabetta Caramelli

6

Elisabetta Caramelli

0 references

Beatrice Vitali

3

Beatrice Vitali

0 references

Karen Manon Lammers

1

Karen Manon Lammers

0 references

author name string

Patrizia Brigidi

2

0 references

Paolo Gionchetti

4

0 references

Fernando Rizzello

5

0 references

Diego Matteuzzi

7

0 references

Massimo Campieri

FEMS Immunology and Medical Microbiology

8

0 references

language of work or name

English

0 references

publication date

22 September 2003

0 references

September 2003

0 references

published in

0 references

volume

38

0 references

issue

2

0 references

page(s)

165-72

0 references

165-172

0 references

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

IMMUNOLOGY: Therapeutic Manipulation of Gut Flora

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Effect of probiotic strains on interleukin 8 production by HT29/19A cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Specific detection of bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Evaluation of media for selective enumeration of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and bifidobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021

Medicinal chemistry and therapeutic potential of CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900144-5

7 January 2021